Price $10.72 |
Market Cap
340.5M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.23
|
P/S
17.62
|
Dividend %
-
|
|
P/CF
245.9
|
P/FCF
5.1
|
Op. Cash Flow
70.8K
|
FCF
2.1
|
|
Op. Margin
-118.80%
|
Net Margin
-66.70%
|
ROE
-3.90%
|
ROI
-4.80%
|
|
ROA
-3.80%
|
EPS Growth
-102.60%
|
Current Ratio
81.5
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| PetIQ Inc (PETQ) | $20.40 | - | - | 669.1M | Strong Buy |
| Lannett Company, Inc. (LCI) | $1.52 | - | - | 71.5M | Strong Buy |
| Recro Pharma Inc (REPH) | $1.56 | - | - | 68.5M | Strong Buy |
| Akumin Inc (AKU) | $1.49 | - | - | 184.9M | Strong Buy |
| Emmaus Life Sciences Inc (EMMA) | $1.46 | - | - | 75M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
